MATERIAL TRANSFER AGREEMENT (Critical Limb Ischemia Trial) By and Between CORAUTUS GENETICS INC., A Delaware Corporation, And CARITAS ST. ELIZABETH’S MEDICAL CENTER OF BOSTON, INC., A Massachusetts Not For Profit Corporation January 6, 2006Material Transfer Agreement • March 20th, 2006 • Corautus Genetics Inc • Biological products, (no disgnostic substances)
THIS MATERIAL TRANSFER AGREEMENT is entered into, effective as of January 6, 2006, by and between CORAUTUS GENETICS INC., a Delaware Corporation (“Corautus”), and CARITAS ST. ELIZABETH’S MEDICAL CENTER OF BOSTON, INC., a Massachusetts Not For Profit Corporation (“Recipient”).
FOURTH AMENDMENT TO THE AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 20th, 2006 • Corautus Genetics Inc • Biological products, (no disgnostic substances)
THIS FOURTH AMENDMENT TO THE AMENDED AND RESTATED LICENSE AGREEMENT (“Amendment”) made as of the 31st day of January, 2006, by and between VASCULAR GENETICS INC., a Delaware corporation (the “Licensee”) and HUMAN GENOME SCIENCES, INC., a Delaware corporation (“HGS”).
THIRD AMENDMENT TO DEVELOPMENT AGREEMENTDevelopment Agreement • March 20th, 2006 • Corautus Genetics Inc • Biological products, (no disgnostic substances)
This THIRD AMENDMENT TO DEVELOPMENT AGREEMENT (“Amendment”) is made as of February 2, 2006, by and between BOSTON SCIENTIFIC CORPORATION (“BSC”), a Delaware corporation, and CORAUTUS GENETICS INC. (the “Company”), a Delaware corporation (each a “Party,” and collectively, the “Parties”).
